Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
Cancer
|
October 13, 2024
Metabolic, cardiac, and bone health testing in patients with prostate cancer on androgen-deprivation therapy: A population-based assessment of adherence to therapeutic monitoring guidelines
Ahmad Mousa, David-Dan Nguyen, Aly-Khan Lalani, et al.
European Urology
|
August 17, 2021
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study
Patrick Cheung, Samir Patel, Scott A North, et al.
Prostate Cancer and Prostatic Diseases
|
February 24, 2022
Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada
Bobby Shayegan, Christopher J D Wallis, Robert J Hamilton, et al.
Urologic Oncology
|
February 26, 2022
Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada
Bobby Shayegan, Christopher J D Wallis, Shawn Malone, et al.
BJUI Compass
|
August 11, 2022
Patterns of care for non-metastatic castration-resistant prostate cancer: A population-based study
Shawn Malone, Christopher J D Wallis, Richard Lee-Ying, et al.
The Lancet. Oncology
|
November 18, 2022
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)
Shankar Siva, Muhammad Ali, Rohann J M Correa, et al.
Current Oncology (Toronto, Ont.)
|
May 26, 2026
Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis
Ealia Khosh Kish, Erind Dvorani, Refik Saskin, et al.
JAMA Network Open
|
August 20, 2025
Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials
Soumyajit Roy, Zeynep Irem Ozay, Avirup Guha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2021
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update
Katherine S Virgo, R Bryan Rumble, Ronald de Wit, et al.
European Urology Oncology
|
July 10, 2024
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney
Vivian S Tan, Rohann J M Correa, Andrew Warner, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
Cancer
|
October 13, 2024
Metabolic, cardiac, and bone health testing in patients with prostate cancer on androgen-deprivation therapy: A population-based assessment of adherence to therapeutic monitoring guidelines
Ahmad Mousa, David-Dan Nguyen, Aly-Khan Lalani, et al.
European Urology
|
August 17, 2021
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study
Patrick Cheung, Samir Patel, Scott A North, et al.
Prostate Cancer and Prostatic Diseases
|
February 24, 2022
Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada
Bobby Shayegan, Christopher J D Wallis, Robert J Hamilton, et al.
Urologic Oncology
|
February 26, 2022
Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in Canada
Bobby Shayegan, Christopher J D Wallis, Shawn Malone, et al.
BJUI Compass
|
August 11, 2022
Patterns of care for non-metastatic castration-resistant prostate cancer: A population-based study
Shawn Malone, Christopher J D Wallis, Richard Lee-Ying, et al.
The Lancet. Oncology
|
November 18, 2022
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)
Shankar Siva, Muhammad Ali, Rohann J M Correa, et al.
Current Oncology (Toronto, Ont.)
|
May 26, 2026
Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis
Ealia Khosh Kish, Erind Dvorani, Refik Saskin, et al.
JAMA Network Open
|
August 20, 2025
Statin Use in Patients With Advanced Prostate Cancer in the TITAN and SPARTAN Trials
Soumyajit Roy, Zeynep Irem Ozay, Avirup Guha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2021
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update
Katherine S Virgo, R Bryan Rumble, Ronald de Wit, et al.
European Urology Oncology
|
July 10, 2024
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney
Vivian S Tan, Rohann J M Correa, Andrew Warner, et al.
Page
of 8